{
    "title": "Individual feed for https://www.medscape.com/cx/rssfeeds/2700.xml",
    "link": "https://www.medscape.com/cx/rssfeeds/2700.xml",
    "description": "Individual feed output.",
    "lastBuildDate": "2025-12-15T11:02:11.636587",
    "items": [
        {
            "title": "EU Clears Generic Sleep Aid for Seniors With Insomnia",
            "link": "https://www.medscape.com/viewarticle/eu-clears-generic-sleep-aid-seniors-insomnia-2025a1000z5j?src=rss",
            "description": "The EMA concluded that Melatomed’s benefits outweigh its risks and supported granting marketing authorizations in Germany, Austria, Denmark, and Swede...",
            "pubDate": "2025-12-15T15:28:19",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture9.png"
        },
        {
            "title": "New EGFR Lung Cancer Drug Nears EU Approval",
            "link": "https://www.medscape.com/viewarticle/new-egfr-lung-cancer-drug-nears-eu-approval-2025a1000z55?src=rss",
            "description": "The third generation EGFR TKI targets EGFR mutant NSCLC, showing improved progression free survival and fewer adverse events than standard therapy. Me...",
            "pubDate": "2025-12-15T14:59:32",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture8.png"
        },
        {
            "title": "First European Guide on Light Therapy in Cancer Care",
            "link": "https://www.medscape.com/viewarticle/first-european-guide-light-therapy-cancer-care-2025a1000z3d?src=rss",
            "description": "AFSOS 2025 introduced the first European reference for photobiomodulation, outlining the evidence, dosing, and clinical use in supportive cancer care....",
            "pubDate": "2025-12-15T12:16:13",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture3.png"
        },
        {
            "title": "Immunome's Tumor Drug Meets Main Goal in Late-stage Study",
            "link": "https://www.medscape.com/s/viewarticle/immunomes-tumor-drug-meets-main-goal-late-stage-study-2025a1000z4c?src=rss",
            "description": "Immunome said on Monday its experimental drug met the main goal in a late-stage study for patients with a rare type of tumor, sending its shares up 34...",
            "pubDate": "2025-12-15T12:16:13",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture6.png"
        },
        {
            "title": "SMC Approves Givinostat for Duchenne Patients in Scotland",
            "link": "https://www.medscape.com/viewarticle/smc-approves-givinostat-duchenne-patients-scotland-2025a1000z1m?src=rss",
            "description": "Scotland’s NHS can now offer givinostat to ambulant children with Duchenne muscular dystrophy, marking a step forward in care. Medscape News UK",
            "pubDate": "2025-12-15T12:08:55",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture6.png"
        }
    ]
}